基于网络药理学探讨五子衍宗丸对环磷酰胺所致骨髓抑制的治疗作用机制OA
Potential mechanisms of the Wuzi Yanzong Pill in the treatment of cyclophosphamide-induced myelosuppression based on network pharmacology
目的:通过网络药理学探讨五子衍宗丸对环磷酰胺(cyclophosphamide,CTX)所致骨髓抑制的治疗作用及其机制.方法:基于网络药理搜索筛选了五子衍宗丸87个活性成分和49个干预骨髓抑制过程的关键靶点,基于京都基因与基因组百科全书(KEGG)富集分析和程度排序,筛选v-akt小鼠胸腺瘤病毒癌基因同源物1(v-akt murine thymoma viral oncogene homolog-1,AKT1)、丝裂原活化蛋白激酶(mitogen-activated protein kinase,MAPK)1和表皮生长因子受体(epidermal growth factor receptor,EGFR)作为关键靶点.建立CTX骨髓抑制小鼠模型,分为对照组、CTX模型组、五子衍宗丸低剂量组、五子衍宗丸中剂量组和五子衍宗丸高剂量组.检测血细胞计数、骨髓有核细胞计数、骨髓细胞增殖、周期和凋亡.以苏木精-伊红(hematoxylin-eosin,HE)染色检测股骨造血干细胞.采用酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)检测血清炎性因子白细胞介素(interleukin,IL)-1β、IL-6和肿瘤坏死因子(tumor necrosis factor,TNF)-α,以及造血相关因子干细胞因子(stem cell factor,SCF)、促红细胞生成素(erythropoietin,EPO)、血小板生成素(thrombopoietin,TPO)和粒细胞-巨噬细胞集落刺激因子(granulocyte-macrophage colony stimulating factor,GM-CSF)表达水平的变化.用定量聚合酶链式反应检测骨髓组织中肥大/干细胞生长因子受体(mast/stem cell growth factor receptor,c-kit)和GM-CSF表达水平的变化,以及肾组织中EPO和TPO表达水平的变化.通过检测骨髓组织AKT1、MAPK1和EGFR蛋白表达水平,探讨五子衍宗丸对CTX诱导的骨髓抑制的疗效和调节机制.结果:与对照组相比,CTX模型组中CTX诱导的小鼠体质量下降,血小板计数(platelet count,PLT)、血红蛋白(haemoglobin,HGB)、红细胞计数(red blood count,RBC)、白细胞计数(white blood cell,WBC)显著减少.骨髓结构被破坏,髓腔内有核细胞显著减少,细胞排列紊乱,脂肪细胞增多,多发性出血.G1和G2期骨髓细胞增加,S期细胞减少.同时,CTX导致增殖减少,小鼠骨髓中可见大量凋亡细胞.血清IL-6、TNF-α和干扰素-γ等炎症因子水平显著升高,而造血相关因子SCF、EPO、TPO和GM-CSF水平显著降低.骨髓组织中c-kit、GM-CSF、AKT1、MAPK1和EGFR mRNA的表达水平,以及肾组织中EPO和TPO的表达水平显著降低.给药不同剂量的五子衍宗丸后,上述指标以良好的剂量依赖性方式在不同程度上反转,其中五子衍宗丸高剂量组为最佳.结论:五子衍宗丸可通过AKT1/MAPK1/EGFR通路改善CTX诱导的血液学异常、骨髓组织损伤、炎性反应和造血功能障碍,从而减轻骨髓抑制.
Objective:To investigate the therapeutic effects and mechanisms of the Wuzi Yanzong Pill(五子衍宗丸,WYP)in the treatment of cyclophosphamide(CTX)-induced myelosuppression.Methods:Based on the web-based pharmacological search,87 active components of WYP and 49 key targets for intervening in myelosuppressive process were screened.AKT1,MAPK1,EGFR were screened as the key target genes based on the KEGG enrichment analysis and degree sorting.A mouse model of CTX-induced myelosuppression was constructed,forty mice were randomly divided into 5 groups,the control group,the model group(CTX),the low dose WYP group(WYP-L),the medium dose WYP group(WYP-M),and high dose WYP group(WYP-H).Blood cell count,bone marrow nucleated cell count,bone marrow cell proliferation,cycle and apoptosis were detected.Hematopoietic stem cells(HSCs)were detected in the femur by hematoxylin-eosin staining(HE staining),and the damage of the bone marrow tissue was evaluated by HE staining and scanning electron microscopy.enzyme-linked immunosorbent assay(ELISA)was used to detect changes in the expression levels of serum inflammatory factors IL-1β,IL-6 and TNF-α,haematopoietic-related factors SCF,EPO,TPO and GM-CSF.qRT-PCR was used to detect the changes in the expression levels of c-kit and GM-CSF in bone marrow tissues,EPO and TPO in renal tissues.The protein expression levels of AKT1,MAPK1 and EGFR in bone marrow tissues were examined to evaluate the efficacy and regulatory mechanism of WYP on CTX-induced myelosuppression.Results:Compared with the control group,CTX-induced mice in the model group lost weight and showed significant decreases in PLT,HGB,RBC,WBC.The bone marrow structure was damaged,with a dramatic reduction of nucleated cells in the lumen,disturbed cell arrangement,increased number of fat cells,and multiple haemorrhages.Bone marrow cells in G1 and G2 phases were increased,and cells in S phase were decreased.Meanwhile,CTX caused a decrease in proliferation and a large number of apoptotic cells in the bone marrow of mice.Serum levels of IL-6,TNF-α and IFN-γ inflammatory factors were significantly increased,and the levels of haematopoietic-related factors SCF,EPO,TPO and GM-CSF were significantly decreased.The mRNA expression levels of c-kit,GM-CSF,AKT1,MAPK1 and EGFR in bone marrow tissues,and EPO and TPO in kidney tissues were significantly decreased.After gavage of different doses of WYP,the above indexes were reversed to different degrees in a good dose-dependent manner,with WYP-H being the best.Conclusion:WYP is able to ameliorate CTX-induced haematological abnormalities,bone marrow tissue damage,inflammation and haematopoietic insufficiency through the AKT1/MAPK1/EGFR pathway,thereby alleviating myelosuppression.
胡志萍;付皓云;胡齐欣;李嫚;郭缇
湖北省肿瘤医院,湖北 武汉,430079湖北省肿瘤医院,湖北 武汉,430079湖北省肿瘤医院,湖北 武汉,430079湖北省肿瘤医院,湖北 武汉,430079湖北省肿瘤医院,湖北 武汉,430079
医药卫生
五子衍宗丸骨髓抑制网络药理学炎症造血
The Wuzi Yanzong PillMyelosuppressionNetwork pharmacologyInflammationHaemopoiesis
《中医临床研究》 2026 (1)
1-11,11
国家中西医协同"旗舰"科室建设项目(国中医药综结合函[2024]221号)湖北省中医药管理局2023―2024年度科研项目(ZY2023F025).
评论